A detailed history of Abound Wealth Management transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Abound Wealth Management holds 16 shares of DVAX stock, worth $208. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 21 23.81%
Holding current value
$208
Previous $236,000 24.15%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$10.05 - $11.61 $50 - $58
-5 Reduced 23.81%
16 $179,000
Q4 2023

Aug 08, 2024

BUY
$13.09 - $14.98 $274 - $314
21 New
21 $294,000

Others Institutions Holding DVAX

About DYNAVAX TECHNOLOGIES CORP


  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.65B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.